Securing Commercial Nucleic Acid Synthesis.

Area of Science:

• Biosecurity
• Synthetic Biology
• Molecular Biology

Background:

• On-demand gene synthesis provides custom DNA and RNA for research.
• Increasing accessibility of synthetic nucleic acids poses a biosecurity risk due to potential misuse for creating biological weapons.
• Current screening of customers and orders by gene synthesis providers is voluntary and lacks universal standards.

Purpose of the Study:

• To assess the current state of commercial gene synthesis screening.
• To summarize proposals for enhancing screening protocols.
• To provide recommendations for implementing comprehensive screening policies to secure nucleic acid synthesis.

Main Methods:

• Review of government screening guidelines.
• Analysis of industry consortium requirements.
• Examination of legislative proposals and scientific literature.

Main Results:

• There is no legal requirement for gene synthesis providers to screen orders for harmful purposes.
• Voluntary screening practices vary widely across the industry.
• Existing guidelines and proposals offer a foundation for improved security measures.

Conclusions:

• Comprehensive screening policies are crucial for mitigating biosecurity risks associated with synthetic nucleic acids.
• Recommendations aim to strengthen government and industry efforts in securing commercial gene synthesis.
• Implementing standardized screening will enhance the responsible use of gene synthesis technology.